SCHEMBL8701373

SCHEMBL8701373

CC(Cc1ccc(C=O)s1)N(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
SLC6A4 P31645 2/20 0.35
ADRA1D P25100 2/20 0.35
ADRA1A P35348 2/20 0.35
ADRA1B P35368 1/20 0.35
P4HB P07237 1/20 0.32
HTR2A P28223 3/20 0.32
CYP2D6 P10635 2/20 0.32
HTR2C P28335 2/20 0.32
HTR2B P41595 2/20 0.32
LMNA P02545 2/20 0.32
CHRM2 P08172 2/20 0.32
CHRM4 P08173 2/20 0.32
CHRM5 P08912 2/20 0.32
CHRM1 P11229 2/20 0.32
CHRM3 P20309 2/20 0.32
CYP1A2 P05177 1/20 0.32
ALOX15 P16050 1/20 0.32
HSD17B10 Q99714 1/20 0.32
SLC22A1 O15245 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10130976 0.82 ALDH1A1 (0.42) ALDH1A1ADRA1DADRA1AADRA1BCHRM2
SCHEMBL28388882 0.75 PRSS1 (0.44) ALDH1A1ADRA1DADRA1AADRA1BCYP1A2
SCHEMBL11075658 0.74 ALDH1A1 (0.42) ALDH1A1ADRA1DADRA1AADRA1BCYP2D6
SCHEMBL9033324 0.72 SIGMAR1 (0.40) ALDH1A1SLC6A4ADRA1DADRA1AADRA1B
SCHEMBL24025437 0.72 ALDH1A1 (0.38) ALDH1A1ADRA1DADRA1AADRA1BCHRM2
SCHEMBL16901817 0.71 ALDH1A1 (0.40) ALDH1A1ADRA1DADRA1AADRA1BCHRM2
SCHEMBL158329 0.71
SCHEMBL7357004 0.71 ALDH1A1 (0.37) ALDH1A1ADRA1DADRA1AADRA1BHTR2A
SCHEMBL29020313 0.71 ALDH1A1 (0.44) ALDH1A1ADRA1DADRA1AADRA1BCHRM2
SCHEMBL7357007 0.69 ALDH1A1 (0.41) ALDH1A1ADRA1DADRA1AADRA1BLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5834460-A FOR TREATMENT OF BRAIN OR PSYCHOLOGICAL DISORDERS, ALZHEIMER*S DISEASE, MENTAL RETARDATION OR AUTISM YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1998-11-10 US disclosed
EP-0696586-A1 SERINE DERIVATIVE YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1996-02-14 EP disclosed